ARCHIVES

FDA Subcommittee Leaning Toward Mouse-Dog Drug Testing New Preclinical Toxicity-Protocol

This article is from The Cancer Letter archive.

Vol. 05 No. 29 | July 20, 1979

Download PDF Visit The Full Archive

Related Articles

VP Joe Biden Will Not Host Komen’s Global Race for the Cure in D.C.

May 11, 2012

How Cancer Control Grants, Contracts Distributed By States

October 13, 1978

NCAB Agrees With NCI Recommendation To Drop PO1 Chartered Committees, Adopt Single Review

February 13, 1987

ODAC To Advise FDA on First Biosimilars Application Jan. 7

December 19, 2014

Avoiding the Hippocampus During Whole-Brain Radiotherapy Can Preserve Memory Function

September 27, 2013

FDA Says Medicare Policy On ESAs “Consistent With The Available Data.”

October 19, 2007